Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT05636761 |
Other study ID # |
29108019.8.0000.5505 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
April 13, 2020 |
Est. completion date |
February 15, 2023 |
Study information
Verified date |
December 2022 |
Source |
University of Sao Paulo |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The Elite HRV is a reliable HRV analysis tool and could be a valid option to replace the
Polar V800. The objective of study is Comparing the HRV index recorded with the mobile app
Elite HRV and with the multisport watch Polar V800. Individuals will submit to two RR
interval recordings with a Polar H7 strap that sent the data either to the Polar V800 heart
rate monitor or to the Elite HRV app. The volunteers will supine position and breathing
spontaneously, and the RR intervals will collect during 25 minutes. Subsequently, without
warning the subject, the strap will connect to a nother device, and the second 25minute
evaluation was made. The order in which the devices will use is randomized and the HRV
indexes will generated via Kubios HRV.
Description:
Sample Characterization Before starting the evaluation, an anamnesis will apply, in order to
know the individual characteristics of each candidate and verify if he eligible. In addition,
anthropometric variables such as weight, height and Body Mass Index will perform to
characterize the individuals.
Heart Rate Variability (HRV) Heart rate will recorded beat by beat using a heart rate meter
(Polar H10, Polar Electro, Kempele, Finland) at a sampling rate of 5 kHz to assess cardiac
autonomic modulation.
With the chest strap and the receiving and recording device (Elite HRV and Polar V800), the
subjects will be positioned in the supine position and remained at rest with spontaneous
breathing for 25 min. The laboratory temperature was controlled at 20°C, and data
classification was performed in the morning or afternoon, always with a minimum fasting of 2
hours. Participants ask to avoid consuming coffee, chocolate or alcohol and taking medication
the night before. Then, without notifying the subject, the strap will be connect to the other
receiving device and a new 25-minute collection will perform.
For analysis of HRV data, the last 20 minutes of each collection will select. In the future,
the first 1000 beat intervals were chosen and only series with more than 95% of sinus beats
were included in the study, totaling 1000 consecutive RR intervals.
HRV analysis was performed using linear methods, analyzed in the time and frequency domains,
according to the guidelines of the Task Force of the European Society of Cardiology and the
North American Society of Stimulation and Electrophysiology.
STATISTICAL ANALYSIS To determine the difference between the device data, the one-sample
t-test will be use. Pearson's correlation coefficient was chosen to evaluate the correlation
and it was considered null, weak, moderate, strong, very strong or perfect, when,
respectively, r=0; r=0 to 0.3; r=0.3 to 0.6; r=0.6 to 0.9; r=0.9 to 1; r=1.
Bland Altman Plots with limits of agreement of 95% were constructed for all indices in order
to assess agreement and bias between the different forms of HRV capture. In addition, to
analyze the presence of proportion bias, linear regression was used and in case of
non-significance, the hypothesis of proportion bias was discarded.
We also used Multiple Analysis of Variance (MANOVA) for comparison between Groups (started
with Elite HRV versus started with Polar) with Repeated Measures for comparison within
Devices (Elite HRV versus Polar). ANOVA one-way with repeated measures for comparisons of
Devices (without order comparison) was done to determine p value and effect size. Values of p
<0.05 were considered significant. The statistical package used was the Statistical Package
for Social Sciences (SPSS; IBM, Chicago, Illinois, USA), version 26.0.